Rhythm Pharmaceuticals RYTM
NASDAQ RYTM
$93.41 -1.80 (-1.90%)
At close: Oct 1, 2026 · 4:00 PM EDT

Rhythm Pharmaceuticals (RYTM) Accumulated Expenses (2016 - 2026)

Updated

Rhythm Pharmaceuticals (RYTM) posted Accumulated Expenses of $94.02 million for Q2 2026, up 35.9% from $69.19 million a year earlier and up 17.5% from the prior quarter.

Analysis

Rhythm Pharmaceuticals (RYTM) Accumulated Expenses (2016 - 2026) Analysis & Trends

At the end of FY2025, Rhythm Pharmaceuticals' Accumulated Expenses came in at $83.86 million, up 33.8% from FY2024.

  • Annual Accumulated Expenses has increased for five consecutive years, with a five-year compound annual growth rate of 46.2% (FY2020 to FY2025).
  • In prior years, Rhythm Pharmaceuticals' Accumulated Expenses was $62.66 million in FY2024 (+29.8%), $48.26 million in FY2023 (+46.7%), $32.89 million in FY2022 (+9.3%) and $30.08 million in FY2021 (+139.5%).
  • The Q2 2026 figure stands as the highest quarterly Accumulated Expenses in data going back to Q4 2016.
  • On a year-over-year basis, Accumulated Expenses has increased in each of the last 21 quarters, with growth averaging 36.2% over the last eight quarters.
  • Across the past five years, year-over-year growth in Accumulated Expenses ran from 0.3% in Q2 2023 to 252.4% in Q1 2022.
  • According to Business Quant data, Accumulated Expenses for the three prior quarters was $80.05 million (Q1 2026), $83.86 million (Q4 2025) and $84.46 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Rhythm Pharmaceuticals 6.55 Bn 5.42 Bn 62.32 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 94.02 Mn
Mar 31, 2026 80.05 Mn
Dec 31, 2025 83.86 Mn
Sep 30, 2025 84.46 Mn
Jun 30, 2025 69.19 Mn
Mar 31, 2025 59.31 Mn
Dec 31, 2024 62.66 Mn
Sep 30, 2024 54.80 Mn
Jun 30, 2024 48.08 Mn
Mar 31, 2024 44.53 Mn
Dec 31, 2023 48.26 Mn
Sep 30, 2023 44.27 Mn
Jun 30, 2023 35.71 Mn
Mar 31, 2023 30.55 Mn
Dec 31, 2022 32.89 Mn
Sep 30, 2022 25.74 Mn
Jun 30, 2022 35.61 Mn
Mar 31, 2022 25.20 Mn
Dec 31, 2021 30.08 Mn
Sep 30, 2021 18.27 Mn
API Access

Rhythm Pharmaceuticals Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=RYTM&period=max&api_key=YOUR_API_KEY